Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	4.27e-05	2	131	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	4.27e-05	2	131	2	GO:0044017
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	1.28e-04	3	131	2	GO:0043993
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF570 ESR2 SOX30 POU2F2 TEF ZNF786 CREB5 TLX1 HIVEP3 FOXP4 PER2 NFIX TET1 ZNF81 EMX1 MNT EP300 FOXK1 TP53 TBX2	1.74e-04	1244	131	20	GO:0000978
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF570 ESR2 SOX30 POU2F2 TEF CREBBP ZNF786 CREB5 TLX1 HIVEP3 FOXP4 PER2 NFIX TET1 ZNF81 EMX1 PRDM14 MNT EP300 FOXK1 TP53 TBX2	1.99e-04	1459	131	22	GO:0000977
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF570 ESR2 SOX30 POU2F2 TEF ZNF786 CREB5 TLX1 HIVEP3 FOXP4 PER2 NFIX TET1 ZNF81 EMX1 MNT EP300 FOXK1 TP53 TBX2	2.31e-04	1271	131	20	GO:0000987
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	ESR2 CREBBP EP300	3.37e-04	21	131	3	GO:0042975
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TRERF1 MED16 CREBBP PARP10 PER2 NR0B1 KMT2A SPEN LRIF1 EP300 TP53 TBX2	4.56e-04	582	131	12	GO:0140297
GeneOntologyMolecularFunction	transcription corepressor activity	TRERF1 CREBBP PARP10 ATF7IP TLE2 NR0B1 SPEN	7.98e-04	229	131	7	GO:0003714
GeneOntologyBiologicalProcess	embryo development	HSPG2 SHROOM3 INSL3 WNK1 BIRC6 CREBBP WDPCP PTH1R EPN2 FOXP4 CMIP ARID2 BRD4 TET1 NR0B1 KMT2A TSHZ1 EMX1 PRDM14 EP300 TP53 TBX2 SOS1	2.69e-05	1437	129	23	GO:0009790
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	TRERF1 ESR2 SOX30 ATXN1L KANK2 CREBBP PARP10 FOXP4 PER2 NFIX ATF7IP TLE2 TET1 NR0B1 QARS1 SPEN PRDM14 MNT EP300 FOXK1 TP53 TBX2	5.37e-05	1399	129	22	GO:0045892
GeneOntologyBiologicalProcess	transcription initiation-coupled chromatin remodeling	FAM47C TET1 KMT2A EP300 TP53	5.41e-05	65	129	5	GO:0045815
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	TRERF1 ESR2 SOX30 ATXN1L KANK2 CREBBP PARP10 FOXP4 PER2 NFIX ATF7IP TLE2 TET1 NR0B1 QARS1 SPEN PRDM14 MNT EP300 FOXK1 TP53 TBX2	6.23e-05	1413	129	22	GO:1902679
GeneOntologyBiologicalProcess	positive regulation of mitotic cytokinesis	WNK1 ECT2 RAB11FIP3	6.53e-05	13	129	3	GO:1903490
GeneOntologyBiologicalProcess	positive regulation of gene expression, epigenetic	FAM47C TET1 KMT2A EP300 TP53	6.73e-05	68	129	5	GO:0141137
GeneOntologyBiologicalProcess	positive regulation of lymphocyte differentiation	AXL INPP5D CD83 CD27 ARID2 BRD4 EP300	7.25e-05	162	129	7	GO:0045621
GeneOntologyBiologicalProcess	rhythmic process	AXL ESR2 TEF CREBBP OPRL1 PER2 PHLPP1 KMT2A EP300 TP53	9.05e-05	360	129	10	GO:0048511
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	ESR2 SOX30 ATXN1L KANK2 CREBBP FOXP4 PER2 NFIX ATF7IP TET1 NR0B1 SPEN PRDM14 MNT EP300 FOXK1 TP53 TBX2	9.87e-05	1053	129	18	GO:0000122
GeneOntologyBiologicalProcess	regulation of mitotic cytokinesis	WNK1 ECT2 RAB11FIP3	1.26e-04	16	129	3	GO:1902412
HumanPheno	Hirsutism	HSPG2 CREBBP WDPCP NFIX ARID2 BRD4 KMT2A SPEN EP300 TP53	4.23e-06	216	40	10	HP:0001007
HumanPheno	Abnormality of the hairline	HSPG2 CREBBP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	1.01e-05	294	40	11	HP:0009553
HumanPheno	Clinodactyly	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 ADAMTS15 KCNN3 KMT2A SPEN EP300 SOS1	1.36e-05	574	40	15	HP:0030084
HumanPheno	Low anterior hairline	HSPG2 CREBBP ARID2 BRD4 KCNN3 SPEN EP300 TBX2	1.40e-05	147	40	8	HP:0000294
HumanPheno	Abnormality of the scalp hair	HSPG2 KANK2 CREBBP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TP53 TBX2 SOS1	1.44e-05	433	40	13	HP:0100037
HumanPheno	Abnormal 5th finger morphology	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	1.65e-05	509	40	14	HP:0004207
HumanPheno	Thick eyebrow	CREBBP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300	1.97e-05	154	40	8	HP:0000574
HumanPheno	Patent ductus arteriosus	HSPG2 SIK3 CREBBP WDPCP NFIX ARID2 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	2.16e-05	382	40	12	HP:0001643
HumanPheno	Abnormal scalp morphology	HSPG2 KANK2 CREBBP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TP53 TBX2 SOS1	2.18e-05	450	40	13	HP:0001965
HumanPheno	Finger clinodactyly	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	2.29e-05	452	40	13	HP:0040019
HumanPheno	Congenital abnormal hair pattern	HSPG2 CREBBP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	2.76e-05	327	40	11	HP:0011361
HumanPheno	Abnormality of the frontal hairline	HSPG2 CREBBP ARID2 BRD4 KCNN3 SPEN EP300 TBX2 SOS1	3.14e-05	215	40	9	HP:0000599
HumanPheno	Cervical cord compression	CREBBP NFIX EP300	3.65e-05	9	40	3	HP:0002341
HumanPheno	Long eyelashes	HSPG2 CREBBP BRD4 KCNN3 KMT2A SPEN EP300	5.27e-05	129	40	7	HP:0000527
HumanPheno	Clinodactyly of the 5th finger	HSPG2 SIK3 CREBBP WDPCP PTH1R NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	5.58e-05	420	40	12	HP:0004209
HumanPheno	Neoplasm of the central nervous system	HSPG2 CREBBP WDPCP KIAA0753 BRD4 SPEN EP300 TP53	5.60e-05	178	40	8	HP:0100006
HumanPheno	Clinodactyly of hands	HSPG2 SIK3 CREBBP WDPCP PTH1R NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	5.71e-05	421	40	12	HP:0001157
HumanPheno	Deviation of the 5th finger	HSPG2 SIK3 CREBBP WDPCP PTH1R NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	5.71e-05	421	40	12	HP:0009179
HumanPheno	Generalized hirsutism	HSPG2 WDPCP NFIX BRD4 KMT2A SPEN	5.72e-05	89	40	6	HP:0002230
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	6.01e-05	2	40	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	6.01e-05	2	40	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	6.01e-05	2	40	2	HP:0001042
HumanPheno	Hypertrichosis	HSPG2 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TP53	6.27e-05	425	40	12	HP:0000998
HumanPheno	Radial deviation of finger	HSPG2 SIK3 CREBBP WDPCP PTH1R NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	1.05e-04	448	40	12	HP:0009466
HumanPheno	Neoplasm of the nervous system	HSPG2 CREBBP WDPCP KIAA0753 BRD4 SPEN EP300 TP53	1.07e-04	195	40	8	HP:0004375
HumanPheno	Neoplasm by histology	HSPG2 PTH1R KIAA0753 ARID2 BRD4 NR0B1 KCNN3 SPEN EP300 TP53 SOS1	1.18e-04	383	40	11	HP:0011792
HumanPheno	Congenital malformation of the great arteries	HSPG2 ODAD1 SIK3 CREBBP WDPCP NFIX ARID2 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	1.20e-04	529	40	13	HP:0011603
HumanPheno	Radial deviation of the hand or of fingers of the hand	HSPG2 SIK3 CREBBP WDPCP PTH1R NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	1.25e-04	456	40	12	HP:0009485
HumanPheno	Deviation of finger	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	1.41e-04	537	40	13	HP:0004097
HumanPheno	Duplication of phalanx of hallux	CREBBP KIAA0753 EP300	1.54e-04	14	40	3	HP:0010066
HumanPheno	Highly arched eyebrow	SZT2 CREBBP KIAA0753 NFIX BRD4 KMT2A SPEN EP300	1.57e-04	206	40	8	HP:0002553
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	1.79e-04	3	40	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	1.79e-04	3	40	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	1.79e-04	3	40	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	1.79e-04	3	40	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	1.79e-04	3	40	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	1.79e-04	3	40	2	HP:0005895
HumanPheno	Duplication of phalanx of toe	CREBBP KIAA0753 EP300	1.91e-04	15	40	3	HP:0010181
HumanPheno	Abnormal hallux morphology	CREBBP WDPCP PTH1R KIAA0753 NFIX KCNN3 KMT2A EP300	1.92e-04	212	40	8	HP:0001844
HumanPheno	Abnormality of skeletal maturation	HSPG2 CREBBP PTH1R NFIX ARID2 BRD4 NR0B1 KMT2A EP300 TP53 SOS1	1.95e-04	405	40	11	HP:0000927
HumanPheno	Deviation of the hand or of fingers of the hand	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX BRD4 ADAMTS15 KMT2A SPEN EP300 SOS1	2.32e-04	564	40	13	HP:0009484
HumanPheno	Abnormal morphology of the great vessels	HSPG2 ODAD1 SIK3 CREBBP WDPCP PTH1R NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	2.56e-04	736	40	15	HP:0030962
HumanPheno	Tooth malposition	HSPG2 CREBBP WDPCP PTH1R KIAA0753 BRD4 ADAMTS15 KCNN3 SPEN EP300 SOS1	2.58e-04	418	40	11	HP:0000692
HumanPheno	Low posterior hairline	CREBBP NFIX BRD4 KMT2A EP300 SOS1	2.62e-04	117	40	6	HP:0002162
HumanPheno	Abnormality of the posterior hairline	CREBBP NFIX BRD4 KMT2A EP300 SOS1	2.62e-04	117	40	6	HP:0030141
HumanPheno	Abnormal eyelash morphology	HSPG2 KANK2 CREBBP ARID2 BRD4 KCNN3 KMT2A SPEN EP300	2.71e-04	284	40	9	HP:0000499
HumanPheno	Brachydactyly	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 SOS1	3.47e-04	670	40	14	HP:0001156
HumanPheno	Trichiasis	CREBBP EP300	3.57e-04	4	40	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	3.57e-04	4	40	2	HP:0410266
HumanPheno	Talon cusp	CREBBP EP300	3.57e-04	4	40	2	HP:0011087
HumanPheno	Widened distal phalanges	CREBBP EP300	3.57e-04	4	40	2	HP:0006200
HumanPheno	Vascular ring	CREBBP EP300	3.57e-04	4	40	2	HP:0010775
HumanPheno	Hepatic hemangioma	CREBBP EP300	3.57e-04	4	40	2	HP:0031207
HumanPheno	Short digit	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 SOS1	3.58e-04	672	40	14	HP:0011927
HumanPheno	Abnormal eyebrow morphology	HSPG2 SZT2 KANK2 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 SOS1	3.69e-04	674	40	14	HP:0000534
HumanPheno	Abnormal hair pattern	HSPG2 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 TP53 TBX2 SOS1	3.81e-04	676	40	14	HP:0010720
HumanPheno	Truncal obesity	CREBBP WDPCP BRD4 EP300 TP53	4.04e-04	82	40	5	HP:0001956
HumanPheno	Advanced eruption of teeth	CREBBP PTH1R NFIX EP300	4.20e-04	46	40	4	HP:0006288
HumanPheno	Conductive hearing impairment	HSPG2 ODAD1 CREBBP KIAA0753 NFIX ARID2 BRD4 TSHZ1 SPEN EP300	4.54e-04	373	40	10	HP:0000405
HumanPheno	Supernumerary tooth	HSPG2 CREBBP PTH1R KCNN3 EP300	4.78e-04	85	40	5	HP:0011069
HumanPheno	Cryptorchidism	HSPG2 AXL INSL3 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 NR0B1 ADAMTS15 KMT2A SPEN EP300 SOS1	4.89e-04	780	40	15	HP:0000028
HumanPheno	Prominent digit pad	CREBBP NFIX KMT2A EP300	4.95e-04	48	40	4	HP:0011298
HumanPheno	Depressed nasal bridge	HSPG2 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 QARS1 SPEN EP300 TBX2 SOS1	5.22e-04	612	40	13	HP:0005280
HumanPheno	Flattened nasal bridge	HSPG2 CREBBP WDPCP PTH1R KIAA0753 NFIX ARID2 BRD4 QARS1 SPEN EP300 TBX2 SOS1	5.22e-04	612	40	13	HP:0000425
HumanPheno	Deep plantar creases	CREBBP KCNN3 EP300	5.41e-04	21	40	3	HP:0001869
HumanPheno	Abnormality of upper limb joint	HSPG2 SIK3 ANKRD55 CREBBP PTH1R KIAA0753 BRD4 ADAMTS15 KMT2A SPEN LRIF1 EP300 TBX2 SOS1	5.91e-04	705	40	14	HP:0009810
HumanPheno	Papillary cystadenoma of the epididymis	CREBBP EP300	5.92e-04	5	40	2	HP:0009715
HumanPheno	Supernumerary cusp	CREBBP EP300	5.92e-04	5	40	2	HP:0033777
HumanPheno	Epididymal neoplasm	CREBBP EP300	5.92e-04	5	40	2	HP:0030421
HumanPheno	High palate	HSPG2 SIK3 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 ADAMTS15 KCNN3 KMT2A QARS1 SPEN EP300 SOS1	5.95e-04	794	40	15	HP:0000218
HumanPheno	Functional abnormality of the middle ear	HSPG2 ODAD1 CREBBP KIAA0753 NFIX ARID2 BRD4 TSHZ1 SPEN EP300	5.97e-04	386	40	10	HP:0011452
HumanPheno	Abnormal hair quantity	HSPG2 AXL KANK2 CREBBP WDPCP KIAA0753 NFIX ARID2 BRD4 NR0B1 KCNN3 KMT2A SPEN EP300 TP53 SOS1	6.13e-04	888	40	16	HP:0011362
HumanPheno	Long hallux	PTH1R KCNN3 KMT2A	6.23e-04	22	40	3	HP:0001847
HumanPheno	Neoplasm	HSPG2 ATP7B CREBBP WDPCP PTH1R KIAA0753 CD27 NFIX ARID2 BRD4 NR0B1 KCNN3 SPEN EP300 TP53 TBX2 SOS1	6.46e-04	987	40	17	HP:0002664
HumanPheno	Pectus excavatum	HSPG2 SIK3 CREBBP NFIX ARID2 BRD4 KMT2A EP300 SOS1	7.02e-04	323	40	9	HP:0000767
HumanPheno	Puberty and gonadal disorders	HSPG2 ATP7B AXL ODAD1 ESR2 NPHP4 CREBBP WDPCP PTH1R NFIX BRD4 NR0B1 SPEN EP300 TP53 SOS1	7.15e-04	900	40	16	HP:0008373
HumanPheno	Bilateral cryptorchidism	CREBBP KIAA0753 NFIX EP300	7.77e-04	54	40	4	HP:0008689
HumanPheno	Autism	HSPG2 SZT2 CREBBP WDPCP BRD4 KMT2A SPEN EP300	8.45e-04	264	40	8	HP:0000717
HumanPheno	Large foramen magnum	CREBBP EP300	8.84e-04	6	40	2	HP:0002700
HumanPheno	Abnormal finger phalanx morphology	HSPG2 WNK1 CREBBP WDPCP PTH1R KIAA0753 NFIX BRD4 ADAMTS15 KCNN3 KMT2A SPEN EP300 TBX2	9.44e-04	738	40	14	HP:0005918
HumanPheno	Facial hypertrichosis	CREBBP NFIX BRD4 KCNN3 KMT2A SPEN EP300	9.54e-04	206	40	7	HP:0002219
HumanPheno	Hypertelorism	HSPG2 SIK3 CREBBP WDPCP PTH1R KIAA0753 NFIX BRD4 ADAMTS15 KCNN3 KMT2A SPEN EP300 TBX2 SOS1	9.61e-04	830	40	15	HP:0000316
HumanPheno	Minor feet anomalies	CREBBP KCNN3 EP300	1.03e-03	26	40	3	HP:0010613
HumanPheno	Abnormal feet morphology	CREBBP KCNN3 EP300	1.03e-03	26	40	3	HP:0010611
HumanPheno	Annular pancreas	HSPG2 SIK3 SPEN	1.03e-03	26	40	3	HP:0001734
HumanPheno	Downslanted palpebral fissures	SZT2 CREBBP WDPCP NFIX ARID2 BRD4 KCNN3 KMT2A SPEN EP300 SOS1	1.14e-03	497	40	11	HP:0000494
HumanPheno	Abnormal epiphysis morphology	HSPG2 SIK3 WNK1 NPHP4 CREBBP PTH1R KIAA0753 EP300	1.21e-03	279	40	8	HP:0005930
HumanPheno	Deviated nasal septum	CREBBP EP300	1.23e-03	7	40	2	HP:0004411
HumanPheno	Generalized hypertrichosis	KCNN3 KMT2A	1.23e-03	7	40	2	HP:0004554
HumanPheno	Wormian bones	HSPG2 WNK1 NFIX ARID2	1.23e-03	61	40	4	HP:0002645
HumanPheno	Benign neoplasm of the central nervous system	CREBBP WDPCP KIAA0753 EP300 TP53	1.25e-03	105	40	5	HP:0100835
HumanPheno	Low-set ears	HSPG2 CREBBP PTH1R KIAA0753 NFIX ARID2 BRD4 ADAMTS15 KMT2A QARS1 SPEN EP300 TBX2 SOS1	1.29e-03	761	40	14	HP:0000369
HumanPheno	Delayed skeletal maturation	HSPG2 CREBBP ARID2 BRD4 NR0B1 KMT2A EP300 TP53 SOS1	1.30e-03	352	40	9	HP:0002750
HumanPheno	Flat face	HSPG2 CREBBP KIAA0753 KMT2A EP300	1.31e-03	106	40	5	HP:0012368
HumanPheno	Abnormal heart valve morphology	HSPG2 SZT2 ODAD1 CREBBP WDPCP NFIX BRD4 ADAMTS15 SPEN EP300 TBX2 SOS1	1.32e-03	588	40	12	HP:0001654
HumanPheno	Hypoplastic ilia	HSPG2 CREBBP PTH1R EP300	1.39e-03	63	40	4	HP:0000946
HumanPheno	Short columella	CREBBP KMT2A EP300	1.42e-03	29	40	3	HP:0002000
HumanPheno	Broad eyebrow	CREBBP KMT2A EP300	1.42e-03	29	40	3	HP:0011229
HumanPheno	Neoplasm by anatomical site	HSPG2 ATP7B CREBBP WDPCP PTH1R KIAA0753 CD27 NFIX ARID2 BRD4 NR0B1 SPEN EP300 TP53 TBX2 SOS1	1.46e-03	959	40	16	HP:0011793
HumanPheno	Abnormal aortic arch morphology	HSPG2 CREBBP PTH1R SPEN EP300	1.48e-03	109	40	5	HP:0012303
MousePheno	increased megakaryocyte cell number	ESR2 CREBBP ARHGAP21 EP300 SOS1	1.42e-05	45	97	5	MP:0008254
MousePheno	abnormal bone mineralization	HSPG2 ESR2 IRS1 SIK3 PTH1R KIAA1549L PER2 NFIX	3.66e-05	181	97	8	MP:0002896
MousePheno	abnormal myocardium compact layer morphology	HSPG2 SHROOM3 CREBBP ARID2 EP300	9.97e-05	67	97	5	MP:0004056
MousePheno	abnormal neurocranium morphology	HSPG2 SHROOM3 SIK3 CREBBP PTH1R TET1 TSHZ1 MNT SOS1	1.03e-04	269	97	9	MP:0000074
MousePheno	abnormal jugular vein morphology	PTH1R CMIP	1.42e-04	3	97	2	MP:0013872
MousePheno	jugular vein stenosis	PTH1R CMIP	1.42e-04	3	97	2	MP:0013963
MousePheno	increased leukemia incidence	ESR2 CREBBP KMT2A TP53	1.49e-04	39	97	4	MP:0002026
MousePheno	abnormal conotruncal ridge morphology	HSPG2 SHROOM3 TBX2	2.05e-04	17	97	3	MP:0010585
MousePheno	abnormal conotruncus morphology	HSPG2 SHROOM3 TBX2	2.45e-04	18	97	3	MP:0010583
MousePheno	abnormal digestive system morphology	HSPG2 SHROOM3 INPP5D ESR2 NBEA CREBBP WDPCP PTH1R FOXP4 CMIP PER2 NFIX TET1 TSHZ1 GAST MNT EP300 TP53 TBX2 SOS1	2.61e-04	1233	97	20	MP:0000462
MousePheno	abnormal hematopoietic stem cell physiology	PER2 KMT2A ARHGAP21 TP53	2.61e-04	45	97	4	MP:0010763
MousePheno	thin myocardium compact layer	SHROOM3 CREBBP ARID2 EP300	2.84e-04	46	97	4	MP:0004057
MousePheno	increased tumor incidence	IL12RB2 INPP5D ESR2 CREBBP PTH1R HIVEP3 PER2 TET1 NR0B1 KMT2A GAST TP53	2.95e-04	530	97	12	MP:0002020
MousePheno	abnormal cartilaginous joint morphology	HSPG2 SIK3 PTH1R NFIX TSHZ1	3.07e-04	85	97	5	MP:0030875
MousePheno	increased classified tumor incidence	IL12RB2 INPP5D ESR2 CREBBP PTH1R HIVEP3 PER2 TET1 KMT2A TP53	3.07e-04	381	97	10	MP:0010273
MousePheno	myocardium hypoplasia	SHROOM3 WNK1 CREBBP RBM24 EP300	3.24e-04	86	97	5	MP:0010500
MousePheno	abnormal megakaryocyte morphology	ESR2 CREBBP ARHGAP21 EP300 SOS1	3.24e-04	86	97	5	MP:0002417
MousePheno	abnormal classified tumor incidence	IL12RB2 INPP5D ESR2 CREBBP PTH1R HIVEP3 PER2 TET1 KMT2A TP53	3.27e-04	384	97	10	MP:0020188
MousePheno	thin ventricle myocardium compact layer	SHROOM3 CREBBP EP300	3.39e-04	20	97	3	MP:0010556
MousePheno	abnormal cardiovascular development	HSPG2 IL12RB2 SHROOM3 WNK1 BIRC6 CREBBP WDPCP FOXP4 CMIP ARID2 RBM24 SPEN EP300 TP53 TBX2	3.97e-04	802	97	15	MP:0002925
MousePheno	abnormal bone ossification	HSPG2 ESR2 IRS1 SIK3 CREBBP PTH1R HIVEP3 KIAA1549L PER2 NFIX	4.08e-04	395	97	10	MP:0008271
MousePheno	abnormal granulocyte number	ATP7B ARHGEF5 INPP5D TICAM1 ESR2 SIK3 CREBBP TLX1 TET1 KMT2A RFT1 ARHGAP21 EP300 TP53 SOS1	4.13e-04	805	97	15	MP:0020201
MousePheno	abnormal tumor incidence	IL12RB2 INPP5D ESR2 CREBBP PTH1R HIVEP3 CMIP PER2 TET1 NR0B1 KMT2A GAST TP53	4.30e-04	635	97	13	MP:0002019
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	4.96e-05	2	132	2	IPR014744
Domain	ZnF_TAZ	CREBBP EP300	4.96e-05	2	132	2	SM00551
Domain	-	CREBBP EP300	4.96e-05	2	132	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	4.96e-05	2	132	2	IPR010303
Domain	-	CREBBP EP300	4.96e-05	2	132	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	4.96e-05	2	132	2	PF09030
Domain	zf-TAZ	CREBBP EP300	4.96e-05	2	132	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	4.96e-05	2	132	2	PS50134
Domain	KAT11	CREBBP EP300	4.96e-05	2	132	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	4.96e-05	2	132	2	IPR000197
Domain	KIX	CREBBP EP300	4.96e-05	2	132	2	PF02172
Domain	HAT_KAT11	CREBBP EP300	4.96e-05	2	132	2	PF08214
Domain	KIX	CREBBP EP300	4.96e-05	2	132	2	PS50952
Domain	CBP_P300_HAT	CREBBP EP300	4.96e-05	2	132	2	IPR031162
Domain	DUF902	CREBBP EP300	4.96e-05	2	132	2	PF06001
Domain	-	CREBBP EP300	4.96e-05	2	132	2	1.10.246.20
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	4.96e-05	2	132	2	IPR013178
Domain	KIX_dom	CREBBP EP300	4.96e-05	2	132	2	IPR003101
Domain	CBP_P300_HAT	CREBBP EP300	4.96e-05	2	132	2	PS51727
Domain	NPIP	NPIPB3 NPIPB5 NPIPB13	1.19e-04	14	132	3	IPR009443
Domain	BROMODOMAIN_2	CREBBP BRD4 KMT2A EP300	1.97e-04	41	132	4	PS50014
Domain	Bromodomain	CREBBP BRD4 KMT2A EP300	2.17e-04	42	132	4	IPR001487
Domain	BROMO	CREBBP BRD4 KMT2A EP300	2.17e-04	42	132	4	SM00297
Domain	-	CREBBP BRD4 KMT2A EP300	2.17e-04	42	132	4	1.20.920.10
Domain	Nuc_rcpt_coact	CREBBP EP300	7.30e-04	6	132	2	IPR009110
Domain	Bromodomain_CS	CREBBP BRD4 EP300	7.97e-04	26	132	3	IPR018359
Domain	PH	ARHGEF5 IRS1 ECT2 CMIP OSBPL7 PHLPP1 ARHGAP21 SOS1	8.17e-04	278	132	8	SM00233
Domain	PH_DOMAIN	ARHGEF5 IRS1 ECT2 CMIP OSBPL7 PHLPP1 ARHGAP21 SOS1	8.37e-04	279	132	8	PS50003
Domain	PH_domain	ARHGEF5 IRS1 ECT2 CMIP OSBPL7 PHLPP1 ARHGAP21 SOS1	8.56e-04	280	132	8	IPR001849
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	TICAM1 CREBBP EP300	1.99e-05	9	89	3	M47451
Pathway	BIOCARTA_CARM_ER_PATHWAY	CREBBP NR0B1 SPEN EP300	2.00e-05	26	89	4	M2499
Pathway	REACTOME_SIGNALING_BY_NOTCH1	NBEA CREBBP TLE2 DTX2 EP300	1.02e-04	74	89	5	M616
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	CAD IRS1 CREBBP TLE2 TET1 NR0B1 EP300 TP53 SOS1	1.17e-04	301	89	9	MM15983
Pathway	PID_MYC_ACTIV_PATHWAY	CAD BCAT1 CREBBP EP300 TP53	1.40e-04	79	89	5	M66
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	CREBBP EP300 TP53	1.55e-04	17	89	3	M48025
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	NBEA CREBBP TLE2 EP300	2.34e-04	48	89	4	M611
Pathway	KEGG_PROSTATE_CANCER	CREBBP CREB5 EP300 TP53 SOS1	2.45e-04	89	89	5	M13191
Pathway	WP_IL4_SIGNALING	INPP5D IRS1 EP300 SOS1	3.69e-04	54	89	4	M39720
Pathway	WP_HEPATITIS_B_INFECTION	HSPG2 TICAM1 CREBBP CREB5 EP300 SOS1	3.82e-04	151	89	6	M39801
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	3.89e-04	5	89	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	3.89e-04	5	89	2	M48023
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	3.89e-04	5	89	2	MM1575
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	3.89e-04	5	89	2	M27228
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 ATXN1L CREBBP PRR12 FOXP4 ARID2 TET1 KMT2A SPEN LRIF1 EP300 FOXK1 TBX2	1.88e-09	351	139	13	38297188
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 CRYBG2 SHROOM3 SZT2 IRS1 WNK1 NPHP4 BIRC6 HIVEP3 PRR12 PER2 BRD4 PCNX1 DTX2 MAPKBP1 SPEN ARHGAP21 EP300 CEP170B FOXK1 RAB11FIP3	3.32e-09	1105	139	21	35748872
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 ESR2 SOX30 POU2F2 TEF CREB5 TLX1 HIVEP3 FOXP4 NFIX NR0B1 KMT2A TSHZ1 EMX1 MNT FOXK1 MBNL3 TP53 TBX2	4.29e-09	908	139	19	19274049
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	POU2F2 ECT2 KANK2 LENG9 CREBBP CREB5 FOXP4 NFIX FBXO42 TSHZ1 KIF5B QARS1 SPEN MNT EP300 FOXK1 TP53 TBX2	1.07e-08	857	139	18	25609649
Pubmed	Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.	ESR2 CREBBP EP300 TP53	5.04e-08	10	139	4	18765668
Pubmed	Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer.	ESR2 CREBBP EP300	6.25e-08	3	139	3	20859991
Pubmed	Synergistic activation of transcription by CBP and p53.	CREBBP EP300 TP53	6.25e-08	3	139	3	9194564
Pubmed	p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300.	CREBBP EP300 TP53	6.25e-08	3	139	3	11782467
Pubmed	Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.	CREBBP EP300 TP53	6.25e-08	3	139	3	14759370
Pubmed	Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.	CREBBP EP300 TP53	6.25e-08	3	139	3	19166313
Pubmed	A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.	TRERF1 CREBBP EP300	6.25e-08	3	139	3	11349124
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 ARHGEF5 IRS1 SIK3 WNK1 ECT2 EPN2 KIAA0753 PIK3R4 BRD4 TET1 KMT2A KIF5B ARHGAP21 CEP170B FOXK1 TP53	6.88e-08	861	139	17	36931259
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 MED16 ATXN1L CREBBP PRR12 FOXP4 NFIX BRD4 KMT2A FOXK1	1.39e-07	268	139	10	33640491
Pubmed	Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.	CREBBP EP300 TP53	2.49e-07	4	139	3	16611888
Pubmed	Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis.	CREBBP EP300 TP53	2.49e-07	4	139	3	18552833
Pubmed	Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).	CREBBP EP300 TP53	2.49e-07	4	139	3	16537920
Pubmed	Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.	CREBBP EP300 TP53	2.49e-07	4	139	3	19651603
Pubmed	Binding and modulation of p53 by p300/CBP coactivators.	CREBBP EP300 TP53	2.49e-07	4	139	3	9194565
Pubmed	NF-kappaB RelA phosphorylation regulates RelA acetylation.	CREBBP EP300 TP53	2.49e-07	4	139	3	16135789
Pubmed	Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.	CREBBP KMT2A EP300	2.49e-07	4	139	3	17707401
Pubmed	Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.	CREBBP EP300 TP53	2.49e-07	4	139	3	11196199
Pubmed	p300/MDM2 complexes participate in MDM2-mediated p53 degradation.	CREBBP EP300 TP53	2.49e-07	4	139	3	9809062
Pubmed	Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.	CREBBP EP300 TP53	2.49e-07	4	139	3	19880525
Pubmed	Inactivating mutations of acetyltransferase genes in B-cell lymphoma.	CREBBP EP300 TP53	2.49e-07	4	139	3	21390126
Pubmed	Human transcription factor protein interaction networks.	TRERF1 HSPG2 CAD ATXN1L CREBBP TLX1 PRR12 FOXP4 NFIX ATF7IP ARID2 OTUD4 KMT2A QARS1 SPEN MNT LRIF1 EP300 FOXK1 TP53 FILIP1L	2.62e-07	1429	139	21	35140242
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 CAD MED16 INPP5D BCAT1 ATXN1L CREBBP PRR12 ARID2 BRD4 KMT2A KIF5B SPEN MNT LRIF1 EP300 FOXK1 TP53	4.59e-07	1103	139	18	34189442
Pubmed	Induction of SOX4 by DNA damage is critical for p53 stabilization and function.	CREBBP EP300 TP53	6.21e-07	5	139	3	19234109
Pubmed	A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP.	CREBBP EP300 TP53	6.21e-07	5	139	3	14722092
Pubmed	The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.	CREBBP EP300 TP53	6.21e-07	5	139	3	25451029
Pubmed	Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).	CREBBP EP300 TP53	6.21e-07	5	139	3	21670263
Pubmed	Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses.	CREBBP EP300 TP53	6.21e-07	5	139	3	15225550
Pubmed	Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.	CREBBP EP300 TP53	6.21e-07	5	139	3	16543236
Pubmed	Inhibition of p53 degradation by Mdm2 acetylation.	CREBBP EP300 TP53	6.21e-07	5	139	3	15013777
Pubmed	The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.	CREBBP EP300 TP53	6.21e-07	5	139	3	19448667
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CREBBP PRR12 FOXP4 TSR1 NFIX ATF7IP ARID2 BRD4 TSHZ1 EP300 FOXK1	6.48e-07	398	139	11	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WNK1 NPHP4 BIRC6 EPN2 KIAA0753 HIVEP3 PRR12 KRBA1 CMIP ARID2 FBXO42 DTX2	7.55e-07	493	139	12	15368895
Pubmed	Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.	CREBBP BRD4 EP300 TP53	9.04e-07	19	139	4	27626385
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 ESR2 POU2F2 TEF LENG9 ZNF786 HIVEP3 KRBA1 ARID2 BRD4 NR0B1 MNT FOXK1 MBNL3 TP53	9.23e-07	808	139	15	20412781
Pubmed	CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.	CREBBP EP300 TP53	1.24e-06	6	139	3	19805293
Pubmed	Acetylation is indispensable for p53 activation.	CREBBP EP300 TP53	1.24e-06	6	139	3	18485870
Pubmed	A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer.	CREBBP EP300 TP53	1.24e-06	6	139	3	32494626
Pubmed	The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.	CREBBP EP300 TP53	2.16e-06	7	139	3	15154850
Pubmed	Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.	CREBBP EP300 TP53	3.45e-06	8	139	3	10490106
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SHROOM3 ARHGEF5 IRS1 DTX2 KIF5B ARHGAP21	3.59e-06	102	139	6	15778465
Pubmed	A human MAP kinase interactome.	SIK3 WNK1 CREBBP KIAA1549L ATF7IP ARID2 KIF5B WIPF2 EP300 RNF111 SOS1	4.45e-06	486	139	11	20936779
Pubmed	Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages.	CREBBP EP300 TP53	7.34e-06	10	139	3	25314079
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 SHROOM3 ARHGEF5 INPP5D WNK1 ARID2 TSHZ1 SPEN TP53 SOS1	9.71e-06	430	139	10	35044719
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	IL12RB2 ATP7B HAUS5 SIK3 KANK2 CREBBP FOXP4 HMCN2 ARID2 BRD4 EP300 CEP170B FOXK1 TP53 TBX2 SOS1	1.07e-05	1116	139	16	31753913
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MED16 HAUS5 WNK1 KANK2 CREBBP KIAA0753 TSR1 KMT2A KIF5B SPEN LRIF1 EP300	1.17e-05	645	139	12	25281560
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MED16 ESR2 TEF ANKRD55 CREBBP TLX1 PER2 TLE2 EMX1 SPEN PRDM14 EP300 TP53 TBX2	1.21e-05	877	139	14	20211142
Pubmed	Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.	CREBBP PER2 EP300	1.34e-05	12	139	3	14645221
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CAD HAUS5 CREBBP ARID2 BRD4 TET1 KMT2A KIF5B SPEN EP300 TP53	1.39e-05	549	139	11	38280479
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	1.59e-05	2	139	2	27881875
Pubmed	The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression.	IL12RB2 ESR2	1.59e-05	2	139	2	23677568
Pubmed	Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.	TET1 KMT2A	1.59e-05	2	139	2	23100278
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	1.59e-05	2	139	2	34845315
Pubmed	LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).	TET1 KMT2A	1.59e-05	2	139	2	12124344
Pubmed	Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.	TICAM1 SOS1	1.59e-05	2	139	2	15767257
Pubmed	Substrate phosphorylation and feedback regulation in JFK-promoted p53 destabilization.	FBXO42 TP53	1.59e-05	2	139	2	21127074
Pubmed	Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.	EP300 TP53	1.59e-05	2	139	2	12724314
Pubmed	Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma.	ESR2 TP53	1.59e-05	2	139	2	29190668
Pubmed	A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3.	TICAM1 TP53	1.59e-05	2	139	2	36685041
Pubmed	Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.	CREBBP TP53	1.59e-05	2	139	2	26976603
Pubmed	Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.	CREBBP KMT2A	1.59e-05	2	139	2	12205094
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	1.59e-05	2	139	2	20717166
Pubmed	Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.	CREBBP TP53	1.59e-05	2	139	2	19220000
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	1.59e-05	2	139	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	1.59e-05	2	139	2	11559821
Pubmed	Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.	EP300 TP53	1.59e-05	2	139	2	18391200
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	1.59e-05	2	139	2	19822209
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	1.59e-05	2	139	2	21847097
Pubmed	SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.	SOX30 TP53	1.59e-05	2	139	2	25435374
Pubmed	Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling.	PER2 TP53	1.59e-05	2	139	2	25411341
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	1.59e-05	2	139	2	34813504
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	1.59e-05	2	139	2	20301699
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	1.59e-05	2	139	2	35502657
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	1.59e-05	2	139	2	31898871
Pubmed	ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.	ESR2 TP53	1.59e-05	2	139	2	26871946
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	1.59e-05	2	139	2	30888860
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	1.59e-05	2	139	2	27881443
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	1.59e-05	2	139	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	1.59e-05	2	139	2	21803292
Pubmed	BRD4-mediated repression of p53 is a target for combination therapy in AML.	BRD4 TP53	1.59e-05	2	139	2	33431824
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	1.59e-05	2	139	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	1.59e-05	2	139	2	24089570
Pubmed	Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.	AXL TP53	1.59e-05	2	139	2	28596680
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	1.59e-05	2	139	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	1.59e-05	2	139	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	1.59e-05	2	139	2	22303793
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	1.59e-05	2	139	2	34732714
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	1.59e-05	2	139	2	34019788
Pubmed	Structural features of human histone acetyltransferase p300 and its complex with p53.	EP300 TP53	1.59e-05	2	139	2	23010591
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	1.59e-05	2	139	2	9018065
Pubmed	The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.	TET1 KMT2A	1.59e-05	2	139	2	19144982
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	1.59e-05	2	139	2	27380996
Pubmed	CREBBP and p300 lysine acetyl transferases in the DNA damage response.	CREBBP EP300	1.59e-05	2	139	2	29170789
Pubmed	Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.	CREBBP EP300	1.59e-05	2	139	2	21555743
Pubmed	CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.	CREBBP EP300	1.59e-05	2	139	2	12646247
Pubmed	Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing.	PER2 TP53	1.59e-05	2	139	2	27088856
Pubmed	Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.	CREBBP EP300	1.59e-05	2	139	2	11867645
Interaction	TLE3 interactions	TRERF1 ATXN1L CREBBP TLX1 PRR12 NFIX TLE2 ARID2 BRD4 NR0B1 OTUD4 KMT2A SPEN EP300 TP53	3.19e-08	376	134	15	int:TLE3
Interaction	CTBP1 interactions	ESR2 ATXN1L ECT2 CREBBP CREB5 PRR12 BRD4 KMT2A TSHZ1 DTX2 SPEN EP300 FOXK1 TP53 RNF111	8.72e-08	406	134	15	int:CTBP1
Interaction	CRX interactions	TRERF1 SZT2 ATXN1L KANK2 CREBBP PRR12 FOXP4 ARID2 SPEN LRIF1 EP300 FOXK1	1.34e-07	254	134	12	int:CRX
Interaction	BAG2 interactions	MED16 AXL HAUS5 WNK1 NPHP4 ECT2 CREBBP KIAA0753 TLE2 BRD4 OTUD4 PHLPP1 SPEN ARHGAP21 EP300 FOXK1 MBNL3 TP53	1.66e-07	622	134	18	int:BAG2
Interaction	NFIB interactions	ESR2 ATXN1L CREBBP TLX1 PRR12 FOXP4 NFIX BRD4 DTX2	4.59e-07	142	134	9	int:NFIB
Interaction	KLF5 interactions	ESR2 ATXN1L CREBBP PRR12 FOXP4 ARID2 BRD4 EP300 FOXK1 TP53	7.37e-07	195	134	10	int:KLF5
Interaction	SP7 interactions	TRERF1 CAD ATXN1L CREBBP PRR12 FOXP4 NFIX ARID2 QARS1 EP300 FOXK1 FILIP1L	9.14e-07	304	134	12	int:SP7
Interaction	NCOR1 interactions	ESR2 ATXN1L CREBBP TLX1 NFIX BRD4 DTX2 KIF5B SPEN EP300 FOXK1 TP53 TBX2	9.42e-07	363	134	13	int:NCOR1
Interaction	NCOR2 interactions	ESR2 ATXN1L CREBBP TLX1 NFIX BRD4 FBXO42 DTX2 SPEN EP300 TP53	1.57e-06	264	134	11	int:NCOR2
Interaction	EGR2 interactions	TRERF1 ATXN1L CREBBP PRR12 FOXP4 ARID2 TET1 KMT2A EP300	2.17e-06	171	134	9	int:EGR2
Interaction	FHL2 interactions	SOX30 WNK1 KANK2 ANKRD55 CREBBP DTX2 KIF5B SPEN LRIF1 EP300 B3GAT2 FOXK1 RNF111	2.47e-06	396	134	13	int:FHL2
Interaction	HOXA10 interactions	CREBBP BRD4 KMT2A EMX1 EP300 TBX2	3.50e-06	62	134	6	int:HOXA10
Interaction	TOP3B interactions	HSPG2 CRYBG2 SHROOM3 CAD SZT2 IRS1 WNK1 NPHP4 KANK2 BIRC6 HIVEP3 PRR12 PER2 BRD4 OTUD4 PCNX1 DTX2 MAPKBP1 QARS1 SPEN ARHGAP21 EP300 CEP170B FOXK1 TP53 RAB11FIP3	3.77e-06	1470	134	26	int:TOP3B
Interaction	SOX9 interactions	CREBBP PRR12 NFIX ARID2 BRD4 SPEN EP300	3.83e-06	97	134	7	int:SOX9
Interaction	SOX15 interactions	ATXN1L PRR12 FOXP4 NFIX ARID2 EP300 FOXK1 TP53	4.67e-06	141	134	8	int:SOX15
Interaction	NCOA2 interactions	CAD ESR2 KANK2 CREBBP TLX1 KIF5B EP300 TP53	4.67e-06	141	134	8	int:NCOA2
Interaction	IRF7 interactions	CAD TICAM1 CREBBP EMX1 QARS1 EP300 TP53	4.70e-06	100	134	7	int:IRF7
Interaction	FEV interactions	ATXN1L CREBBP PRR12 FOXP4 ARID2 KMT2A EP300 FOXK1 TP53	8.81e-06	203	134	9	int:FEV
Interaction	TBR1 interactions	ATXN1L PRR12 FOXP4 NFIX BRD4 EP300 FOXK1	1.06e-05	113	134	7	int:TBR1
Interaction	NFIC interactions	ESR2 ATXN1L CREBBP TLX1 PRR12 FOXP4 NFIX BRD4 DTX2	1.16e-05	210	134	9	int:NFIC
Interaction	YWHAH interactions	SHROOM3 ARHGEF5 ESR2 IRS1 SIK3 WNK1 ATXN1L ECT2 ANKRD55 CREBBP PTH1R EPN2 KIAA0753 PIK3R4 BRD4 TET1 KMT2A KIF5B ARHGAP21 CEP170B FOXK1	1.23e-05	1102	134	21	int:YWHAH
Interaction	KDM6A interactions	ESR2 CREBBP TLX1 NFIX BRD4 KMT2A FOXK1 TP53	1.30e-05	162	134	8	int:KDM6A
Interaction	CCT8 interactions	CAD ESR2 SIK3 ANKRD55 PIK3R4 PER2 TSR1 TLE2 BRD4 FBXO42 PHLPP1 KIF5B QARS1 TP53	1.83e-05	550	134	14	int:CCT8
Interaction	ERG interactions	CAD ATXN1L CREBBP PRR12 FOXP4 ATF7IP BRD4 EP300 RNF111	1.87e-05	223	134	9	int:ERG
Interaction	YWHAZ interactions	SHROOM3 CAD AXL ARHGEF5 ESR2 IRS1 SIK3 WNK1 ECT2 KANK2 ANKRD55 EPN2 PER2 BRD4 OSBPL7 OTUD4 KMT2A KIF5B ARHGAP21 EP300 CEP170B FOXK1 TP53	1.88e-05	1319	134	23	int:YWHAZ
Interaction	KLF3 interactions	ATXN1L FOXP4 ATF7IP ARID2 KMT2A LRIF1 EP300 FOXK1 TBX2	2.22e-05	228	134	9	int:KLF3
Interaction	TLX1 interactions	ATXN1L CREBBP TLX1 PRR12 FOXP4 EMX1 EP300 FOXK1	2.27e-05	175	134	8	int:TLX1
Interaction	PAX9 interactions	ATXN1L PRR12 FOXP4 NFIX TLE2 EP300 FOXK1	2.63e-05	130	134	7	int:PAX9
Interaction	PRR12 interactions	ESR2 ECT2 TLX1 PRR12 NFIX DTX2	2.68e-05	88	134	6	int:PRR12
Interaction	FLNA interactions	AXL ACAD10 NPHP4 ECT2 ANKRD55 CMIP PER2 TLE2 BRD4 PHLPP1 KIF5B QARS1 ARHGAP21 EP300 TP53	2.75e-05	648	134	15	int:FLNA
Interaction	NFIA interactions	ATXN1L CREBBP TLX1 PRR12 FOXP4 NFIX DTX2 EP300	3.78e-05	188	134	8	int:NFIA
Interaction	MEIS2 interactions	TLX1 BRD4 KMT2A TSHZ1 EMX1 TBX2	3.89e-05	94	134	6	int:MEIS2
Interaction	EPPK1 interactions	AXL ESR2 NPHP4 ECT2 TSR1 PHLPP1 RBM24 TP53	3.93e-05	189	134	8	int:EPPK1
Interaction	PIAS3 interactions	ESR2 CREBBP ATF7IP ARHGAP21 EP300 TP53	4.13e-05	95	134	6	int:PIAS3
Interaction	FYCO1 interactions	ESR2 HAUS5 KIF5B RFT1 EP300 FOXK1	6.51e-05	103	134	6	int:FYCO1
Interaction	HOXB2 interactions	CREBBP FOXP4 DTX2 EP300	9.33e-05	36	134	4	int:HOXB2
Interaction	HNF4A interactions	MED16 CREBBP PRR12 ATF7IP ARID2 NR0B1 SPEN EP300 TP53	9.50e-05	275	134	9	int:HNF4A
Interaction	ARID1A interactions	ECT2 CREBBP TLX1 NFIX ARID2 FBXO42 PHLPP1 EP300 TP53	9.77e-05	276	134	9	int:ARID1A
Interaction	PAX8 interactions	ATXN1L CREBBP PRR12 FOXP4 NFIX EP300	9.87e-05	111	134	6	int:PAX8
Interaction	FOSL1 interactions	TICAM1 CREBBP CREB5 BRD4 EP300	1.03e-04	70	134	5	int:FOSL1
Interaction	S100P interactions	ESR2 WNK1 ATXN1L BRD4 TET1 ARHGAP21 EP300 CEP170B RAB11FIP3	1.06e-04	279	134	9	int:S100P
Interaction	HSP90B1 interactions	CAD AXL ESR2 NPHP4 ECT2 ANKRD55 CCDC112 PER2 TSR1 TLE2 BRD4 KMT2A QARS1 TP53	1.11e-04	650	134	14	int:HSP90B1
Interaction	NUP98 interactions	ESR2 ECT2 CREBBP BRD4 PHLPP1 DTX2 EP300 TP53	1.14e-04	220	134	8	int:NUP98
Interaction	EGR1 interactions	CREBBP ARID2 EP300 TP53 TBX2	1.18e-04	72	134	5	int:EGR1
Interaction	EPG5 interactions	CREBBP ATF7IP TP53	1.23e-04	15	134	3	int:EPG5
Interaction	TBXT interactions	CAD ATXN1L CREBBP PRR12 SPEN EP300	1.26e-04	116	134	6	int:TBXT
Interaction	RORA interactions	CREBBP NR0B1 LRIF1 EP300	1.28e-04	39	134	4	int:RORA
Interaction	NCOA3 interactions	ESR2 KANK2 CREBBP TLX1 BRD4 DTX2 EP300 TP53	1.29e-04	224	134	8	int:NCOA3
Interaction	FCRL6 interactions	FCRL6 TP53	1.31e-04	3	134	2	int:FCRL6
Interaction	YEATS2 interactions	CRYBG2 ESR2 BCAT1 NPHP4 FBXO42 KMT2A TP53	1.38e-04	169	134	7	int:YEATS2
Interaction	KMT2D interactions	ESR2 CREBBP TLX1 NFIX KMT2A EP300 TP53	1.38e-04	169	134	7	int:KMT2D
Interaction	NFIX interactions	ESR2 ATXN1L PRR12 NFIX ARID2 KMT2A DTX2 SPEN	1.41e-04	227	134	8	int:NFIX
Interaction	PLEC interactions	ESR2 WNK1 NPHP4 ECT2 PER2 BRD4 PHLPP1 QARS1 FOXK1 TP53 FILIP1L	1.44e-04	430	134	11	int:PLEC
Interaction	TACC2 interactions	ESR2 CREBBP FBXO42 KIF5B EP300	1.62e-04	77	134	5	int:TACC2
Interaction	SP1 interactions	CAD ESR2 CREBBP ATF7IP NR0B1 KMT2A SPEN ARHGAP21 EP300 TP53	1.68e-04	365	134	10	int:SP1
Interaction	CCT4 interactions	CAD ESR2 SIK3 ECT2 ANKRD55 PIK3R4 TSR1 TLE2 BRD4 FBXO42 PHLPP1 TP53	1.71e-04	515	134	12	int:CCT4
Interaction	JDP2 interactions	CREBBP CREB5 EP300 TP53	1.72e-04	42	134	4	int:JDP2
Interaction	PAX7 interactions	ATXN1L CREBBP PRR12 FOXP4 NFIX EP300	1.82e-04	124	134	6	int:PAX7
Interaction	HNF1A interactions	ATXN1L CREBBP ATF7IP EMX1 EP300	1.94e-04	80	134	5	int:HNF1A
Interaction	ELF1 interactions	ATXN1L NFIX ARID2 KMT2A LRIF1 FOXK1	1.98e-04	126	134	6	int:ELF1
Interaction	KAT2A interactions	MED16 ESR2 CREBBP NFIX BRD4 EP300 TP53	2.04e-04	180	134	7	int:KAT2A
Interaction	SMTN interactions	ESR2 NPHP4 TP53 FILIP1L	2.06e-04	44	134	4	int:SMTN
Interaction	VDR interactions	MED16 CREBBP OTUD4 EMX1 EP300 TP53	2.07e-04	127	134	6	int:VDR
Interaction	SOX7 interactions	CREBBP PRR12 FOXP4 ARID2 EP300	2.18e-04	82	134	5	int:SOX7
Interaction	PPARGC1A interactions	MED16 ESR2 CREBBP EP300 TP53	2.18e-04	82	134	5	int:PPARGC1A
Interaction	FOSL2 interactions	MED16 NBEA CREB5 LRIF1 EP300	2.31e-04	83	134	5	int:FOSL2
Interaction	SIN3A interactions	ESR2 CREBBP PER2 BRD4 TET1 KMT2A MNT EP300 FOXK1 TP53	2.32e-04	380	134	10	int:SIN3A
Interaction	LHX3 interactions	ATXN1L KANK2 CREBBP PRR12 FOXP4 ARID2 FOXK1	2.41e-04	185	134	7	int:LHX3
Interaction	HIVEP1 interactions	ATXN1L CREBBP TLX1 NFIX FBXO42 SPEN TP53	2.50e-04	186	134	7	int:HIVEP1
Interaction	SMARCC1 interactions	CREBBP PTH1R TLX1 TSR1 NFIX ARID2 BRD4 KMT2A EP300 TP53	2.52e-04	384	134	10	int:SMARCC1
Interaction	DBP interactions	TEF KMT2A EP300	2.58e-04	19	134	3	int:DBP
Interaction	IRF4 interactions	ATXN1L PRR12 FOXP4 ARID2 EP300	2.58e-04	85	134	5	int:IRF4
Interaction	PAX2 interactions	ATXN1L PRR12 FOXP4 NFIX PRDM14	2.58e-04	85	134	5	int:PAX2
Interaction	NPIPB13 interactions	NPIPB13 TP53	2.61e-04	4	134	2	int:NPIPB13
Interaction	KANSL3 interactions	ESR2 NFIX BRD4 KMT2A TP53	2.73e-04	86	134	5	int:KANSL3
Interaction	GSC interactions	ATXN1L CREBBP PRR12 FOXP4 EP300	2.88e-04	87	134	5	int:GSC
Interaction	SMG7 interactions	CREBBP KIAA0753 PRR12 TSR1 TLE2 FBXO42 TET1 OTUD4 TP53	2.88e-04	319	134	9	int:SMG7
Interaction	CREB1 interactions	ESR2 CREBBP NFIX ATF7IP BRD4 EP300 TP53 RNF111	3.03e-04	254	134	8	int:CREB1
Interaction	RBPJ interactions	ESR2 CREBBP NFIX FBXO42 KMT2A SPEN EP300 TP53	3.03e-04	254	134	8	int:RBPJ
Interaction	CNTRL interactions	HAUS5 NPHP4 CREBBP KIAA0753 ARHGAP21 CEP170B TP53	3.12e-04	193	134	7	int:CNTRL
Interaction	PLAGL1 interactions	CREBBP EP300 TP53	3.50e-04	21	134	3	int:PLAGL1
Interaction	KLF8 interactions	CREBBP PRR12 FOXP4 ATF7IP ARID2 SPEN MNT EP300 FOXK1	3.61e-04	329	134	9	int:KLF8
Interaction	TADA3 interactions	ESR2 ATF7IP BRD4 KMT2A EP300 TP53	3.63e-04	141	134	6	int:TADA3
Interaction	FOXI1 interactions	CREBBP PRR12 FOXP4 DTX2 EP300	3.73e-04	92	134	5	int:FOXI1
Interaction	MED25 interactions	MED16 ESR2 CREBBP BRD4 TP53	3.92e-04	93	134	5	int:MED25
Interaction	ZNF148 interactions	ESR2 FOXP4 NFIX DTX2 EP300 TP53	4.07e-04	144	134	6	int:ZNF148
Interaction	SMC3 interactions	CAD AXL ESR2 ANKRD55 TLX1 PRR12 NFIX BRD4 OTUD4 EP300	4.07e-04	408	134	10	int:SMC3
Interaction	YWHAB interactions	SHROOM3 AXL ARHGEF5 ESR2 IRS1 SIK3 WNK1 ECT2 ANKRD55 EPN2 PIK3R4 KMT2A KIF5B ARHGAP21 CEP170B FOXK1 TP53	4.07e-04	1014	134	17	int:YWHAB
Interaction	WDR33 interactions	ESR2 ECT2 BRD4 FBXO42 DTX2 TP53	4.22e-04	145	134	6	int:WDR33
Interaction	CLTC interactions	CAD WNK1 ECT2 ANKRD55 EPN2 PER2 TLE2 BRD4 FBXO42 PHLPP1 QARS1 EP300 TP53	4.32e-04	655	134	13	int:CLTC
Interaction	SOX17 interactions	ATXN1L PRR12 FOXP4 NFIX ARID2	4.33e-04	95	134	5	int:SOX17
Interaction	HDC interactions	DTX2 TP53	4.33e-04	5	134	2	int:HDC
Interaction	SPO11 interactions	ESR2 TP53	4.33e-04	5	134	2	int:SPO11
Interaction	MYH9 interactions	SHROOM3 CAD ESR2 WNK1 NPHP4 ECT2 CREBBP TSR1 BRD4 PHLPP1 KIF5B ARHGAP21 EP300 TP53	5.04e-04	754	134	14	int:MYH9
Interaction	SMARCA2 interactions	IL12RB2 ESR2 CREBBP TLX1 NFIX ARID2 BRD4 KMT2A EP300	5.20e-04	346	134	9	int:SMARCA2
Interaction	TFAP2B interactions	ESR2 CREBBP TP53	5.25e-04	24	134	3	int:TFAP2B
Interaction	WWTR1 interactions	HAUS5 CREBBP ARID2 BRD4 KMT2A DTX2 KIF5B EP300 TP53 TBX2	5.29e-04	422	134	10	int:WWTR1
Interaction	USP9X interactions	AXL ESR2 IRS1 ECT2 ANKRD55 TSR1 FBXO42 OTUD4 EP300 TP53	5.29e-04	422	134	10	int:USP9X
Interaction	TFAP4 interactions	TLX1 NFIX ARID2 BRD4 FOXK1 TP53	5.61e-04	153	134	6	int:TFAP4
Interaction	CAPN1 interactions	ESR2 ECT2 BIRC6 BRD4 QARS1 EP300 TP53	5.96e-04	215	134	7	int:CAPN1
Cytoband	19p13.3	MED16 TICAM1 CAPS ZNRF4 NFIX TLE2 GRIN3B MADCAM1	7.05e-07	237	139	8	19p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	MED16 TICAM1 INSL3 CAPS ZNRF4 KANK2 NFIX TLE2 BRD4 GRIN3B MADCAM1	3.37e-05	797	139	11	chr19p13
Cytoband	16p12.2	NPIPB4 NPIPB3 NPIPB5	1.96e-04	37	139	3	16p12.2
GeneFamily	Immunoglobulin like domain containing	HSPG2 AXL FCRL6 NEO1 HMCN2 MADCAM1	4.30e-04	193	91	6	594
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	IRS1 NPIPB5 CREBBP PIK3R4 PER2 OTUD4 PHLPP1 DTX2 SPEN MNT	4.82e-06	300	139	10	M8702
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NPIPB4 NPIPB3 SIK3 NPIPB5 BIRC6 CMIP FMN1 DGKI PCNX1 RNF111	5.51e-10	193	139	10	779276e775cb2492e8dd36436295a536084a6415
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NPIPB4 SIK3 BIRC6 ATF7IP ARID2 KMT2A PCNX1 SPEN	1.41e-07	188	139	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	IRS1 BIRC6 CREBBP ARID2 KIF5B EP300 SOS1	1.99e-06	186	139	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF570 ECT2 FOXP4 OSBPL7 MBNL3 TP53	1.00e-05	157	139	6	bd45590da540a557dc8096980a45220fccb99505
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF570 ECT2 FOXP4 OSBPL7 MBNL3 TP53	1.00e-05	157	139	6	00c9a58b033b8b95b0d838f233dd077b62d8b02a
ToppCell	390C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SHROOM3 ZNF570 POU2F2 EPN2 OSBPL7 SOS1	1.20e-05	162	139	6	45be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell	390C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SHROOM3 ZNF570 POU2F2 EPN2 OSBPL7 SOS1	1.20e-05	162	139	6	fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCell	356C-Lymphocytic-ILC-ILC-3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CAD ZNF570 SIK3 EPN2 PCNX1 NDUFV1-DT	1.24e-05	163	139	6	2dbdcbc4c187aad3db837d191cc78662a75dd0b5
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TRERF1 IRS1 LENG9 KIAA1549L NFIX PHLPP1	1.58e-05	170	139	6	fefb07a7e308b620f946b9ff2b01e1796446fe38
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CRYBG2 NPIPB13 ARID2 ZNF81 MAPKBP1 B3GAT2	2.11e-05	179	139	6	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AXL IRS1 PTH1R CREB5 FILIP1L TBX2	2.32e-05	182	139	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL KANK2 PTH1R RBM24 FILIP1L TBX2	2.47e-05	184	139	6	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL KANK2 PTH1R RBM24 FILIP1L TBX2	2.47e-05	184	139	6	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	IL12RB2 NPIPB5 BIRC6 ARID2 SPEN RNF111	3.04e-05	191	139	6	9454f642c3621370fa23640b631301346b300950
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	INPP5D ATXN1L PRR12 OTUD4 FOXK1 RNF111	3.13e-05	192	139	6	efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL KANK2 ADAMTS15 RBM24 FILIP1L TBX2	3.32e-05	194	139	6	bf34737ae2dc218f890fbb9201c308b324415749
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL KANK2 ADAMTS15 RBM24 FILIP1L TBX2	3.32e-05	194	139	6	b35e33439b6d3b5d69147e617224d2c8fd056223
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL KANK2 ADAMTS15 RBM24 FILIP1L TBX2	3.32e-05	194	139	6	4ebed7a6731b88c8359860072cbeba355a7e90ac
ToppCell	droplet-Heart-HEART-1m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL BCAT1 IRS1 TEF ADAMTS15 TBX2	3.52e-05	196	139	6	1eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCell	distal-Endothelial-Bronchial_Vessel_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 INPP5D NBEA CREB5 KCNN3 FILIP1L	3.62e-05	197	139	6	9fcfbfbe78e8fe90c76eb37a58ed9dc8ece652a1
ToppCell	distal-3-Endothelial-Bronchial_Vessel_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 INPP5D NBEA CREB5 KCNN3 FILIP1L	3.72e-05	198	139	6	f701d06e3d7fd2192afae3698c5ec3c355e96da3
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AXL KANK2 PTH1R CREB5 FILIP1L TBX2	3.83e-05	199	139	6	9a08c25bb4851ad4ac9db8916422280f71378c2c
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AXL KANK2 PTH1R CREB5 FILIP1L TBX2	3.83e-05	199	139	6	2ed10c5e15c9d5ed0a8bea580842348d5698a07b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	LMNTD2 BCAT1 PTH1R FOXP4 ALAS1 CEP170B	3.93e-05	200	139	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
Disease	Carcinoma, Transitional Cell	ESR2 CREBBP KMT2A EP300 TP53	1.01e-06	41	130	5	C0007138
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	CREBBP KMT2A PRDM14 EP300 TP53	7.50e-06	61	130	5	C1961102
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	1.93e-05	2	130	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	1.93e-05	2	130	2	cv:C4551859
Disease	Menke-Hennekam syndrome	CREBBP EP300	1.93e-05	2	130	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	1.93e-05	2	130	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	1.93e-05	2	130	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	1.93e-05	2	130	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	1.93e-05	2	130	2	DOID:1933 (is_implicated_in)
Disease	tuberculin skin test reactivity measurement	SLC1A7 PODN	1.93e-05	2	130	2	EFO_0008307
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	1.93e-05	2	130	2	C0035934
Disease	Prostatic Neoplasms	ATP7B ARHGEF5 ESR2 IRS1 CREBBP FOXP4 ARID2 BRD4 KMT2A SPEN TP53	9.27e-05	616	130	11	C0033578
Disease	Malignant neoplasm of prostate	ATP7B ARHGEF5 ESR2 IRS1 CREBBP FOXP4 ARID2 BRD4 KMT2A SPEN TP53	9.27e-05	616	130	11	C0376358
Disease	Small cell carcinoma of lung	CREBBP KMT2A EP300 TP53	9.59e-05	54	130	4	C0149925
Disease	asthma, age at diagnosis	TEF MUCL3	1.15e-04	4	130	2	EFO_0004918, MONDO_0004979
Disease	thiosulfate sulfurtransferase measurement	SLC1A7 PODN	2.86e-04	6	130	2	EFO_0802130
Disease	acute lymphoblastic leukemia (implicated_via_orthology)	TEF KMT2A	2.86e-04	6	130	2	DOID:9952 (implicated_via_orthology)
Disease	Bladder Neoplasm	ESR2 CREBBP KMT2A EP300 TP53	3.98e-04	140	130	5	C0005695
Disease	Nephronophthisis, familial juvenile	NPHP4 MAPKBP1	3.99e-04	7	130	2	C1855681
Disease	folding of antihelix	DCHS2 CREB5	3.99e-04	7	130	2	EFO_0007671
Disease	Malignant neoplasm of urinary bladder	ESR2 CREBBP KMT2A EP300 TP53	4.12e-04	141	130	5	C0005684
Disease	pulse pressure measurement	SHROOM3 NBEA ACAD10 CREB5 OPRL1 KIAA0753 PIK3R4 HIVEP3 KIAA1549L TET1 OSBPL7 ADAMTS15 KIF5B TP53 FILIP1L TBX2	4.22e-04	1392	130	16	EFO_0005763
Disease	Acute erythroleukemia - M6a subtype	KMT2A TP53	5.30e-04	8	130	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	KMT2A TP53	5.30e-04	8	130	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	KMT2A TP53	5.30e-04	8	130	2	C2930977
Disease	Acute erythroleukemia	KMT2A TP53	5.30e-04	8	130	2	C2930974
Disease	Cornelia De Lange Syndrome	BRD4 KMT2A	5.30e-04	8	130	2	C0270972
Disease	prostate carcinoma	SHROOM3 ESR2 POU2F2 WDPCP FOXP4 FMN1 KCNN3 TSHZ1 SPEN LRIF1 TP53 SOS1	5.92e-04	891	130	12	EFO_0001663
Disease	cup-to-disc ratio measurement	SLC1A7 CREB5 KIAA1549L TET1 ADAMTS15 KMT2A FOXK1 FILIP1L	6.59e-04	430	130	8	EFO_0006939
Disease	spinal muscular atrophy (implicated_via_orthology)	ATP7B KIF5B	6.80e-04	9	130	2	DOID:12377 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	TRERF1 ATP7B TICAM1 ESR2 SIK3 WNK1 ECT2 PIK3R4 FOXP4 PER2 SPEN EP300 TP53	9.40e-04	1074	130	13	C0006142
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	IL12RB2 CD83 ANKRD55 HIVEP3 CEP170B	9.59e-04	170	130	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	Malignant neoplasm of kidney	ATP7B AXL TP53	1.04e-03	45	130	3	C0740457
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP KMT2A	1.24e-03	12	130	2	DOID:9119 (implicated_via_orthology)
Disease	atrial fibrillation	HSPG2 ESR2 ACAD10 CREB5 KCNN3 SPEN ARHGAP21	1.32e-03	371	130	7	EFO_0000275
Disease	fibrinogen measurement	DCHS2 ACAD10 PRR12 PARP10	1.40e-03	109	130	4	EFO_0004623
Disease	L2 Acute Lymphoblastic Leukemia	KMT2A PRDM14 TP53	1.41e-03	50	130	3	C0023453
Disease	Benign tumor of pancreas	EP300 TP53	1.46e-03	13	130	2	C0347284
Disease	Squamous cell carcinoma of the head and neck	ATP7B IRS1 TP53	1.58e-03	52	130	3	C1168401
Disease	Childhood Acute Lymphoblastic Leukemia	KMT2A PRDM14 TP53	1.58e-03	52	130	3	C0023452
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	SIK3 RNF111	1.69e-03	14	130	2	OBA_2045142
Disease	Carcinoma, Granular Cell	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0205644
Disease	Adenocarcinoma, Tubular	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0205642
Disease	Carcinoma, Cribriform	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0205643
Disease	Adenocarcinoma, Basal Cell	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0205641
Disease	Adenocarcinoma	ESR2 KMT2A GAST TP53	1.76e-03	116	130	4	C0001418
Disease	red blood cell density measurement	NRN1L SHROOM3 ESR2 ACAD10 SIK3 WNK1 ANKRD55 FMN1 ARID2 BRD4 OTUD4	1.81e-03	880	130	11	EFO_0007978
Disease	Diffuse Large B-Cell Lymphoma	CREBBP SPEN EP300	1.85e-03	55	130	3	C0079744
Disease	colorectal cancer (is_implicated_in)	ESR2 ARID2 EP300 TP53	2.05e-03	121	130	4	DOID:9256 (is_implicated_in)
Disease	T-Cell Lymphoma	EP300 TP53	2.22e-03	16	130	2	C0079772
Disease	cholesterol in medium HDL measurement	SIK3 LCAT CMIP	2.27e-03	59	130	3	EFO_0021903
Disease	triglycerides to total lipids in large HDL percentage	SIK3 LCAT CMIP	2.38e-03	60	130	3	EFO_0022330
Disease	cholesterol to total lipids in medium HDL percentage	SIK3 LCAT CMIP	2.38e-03	60	130	3	EFO_0022237
Disease	free cholesterol in HDL measurement	SIK3 LCAT CMIP	2.50e-03	61	130	3	EFO_0022264
Disease	response to vaccine, cytokine measurement	DCHS2 SMIM33 RFT1 ARHGAP21	2.74e-03	131	130	4	EFO_0004645, EFO_0004873
Disease	attention deficit hyperactivity disorder, schizophrenia	CREB5 DGKI RFT1	2.86e-03	64	130	3	EFO_0003888, MONDO_0005090
Disease	mean reticulocyte volume	NRN1L CAD TEF OPRL1 NFIX ATF7IP BRD4 OTUD4 ARHGAP21 TP53	2.89e-03	799	130	10	EFO_0010701
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 PTH1R	3.14e-03	19	130	2	DOID:2256 (is_implicated_in)
Disease	Pancreatic carcinoma	EP300 TP53	3.14e-03	19	130	2	C0235974
Disease	Dyschondroplasias	HSPG2 PTH1R	3.14e-03	19	130	2	C0013366
Disease	Neoplastic Cell Transformation	IRS1 TLX1 PHLPP1 TP53	3.39e-03	139	130	4	C0007621
Disease	end stage renal disease (implicated_via_orthology)	IRS1 LCAT	3.47e-03	20	130	2	DOID:783 (implicated_via_orthology)
Disease	insomnia measurement	PTH1R PER2 KMT2A DGKI MNT ARHGAP21 EP300	3.56e-03	443	130	7	EFO_0007876
Disease	Precursor B-cell lymphoblastic leukemia	KMT2A TP53	3.83e-03	21	130	2	C1292769
Disease	Colorectal Carcinoma	CAD ATP7B ESR2 WNK1 SLC1A7 HIVEP3 ADAMTS15 EP300 TP53	3.99e-03	702	130	9	C0009402
Disease	testosterone measurement	DCHS2 SHROOM3 ESR2 BIRC6 OPRL1 KIAA0753 CMIP NR0B1 DGKI MUCL3 ARHGAP21 TP53 SOS1	4.19e-03	1275	130	13	EFO_0004908
Disease	osteoporosis (biomarker_via_orthology)	ESR2 IRS1	4.20e-03	22	130	2	DOID:11476 (biomarker_via_orthology)
Disease	cognitive function measurement	SYNDIG1L SZT2 NBEA TEF BIRC6 WDPCP PRR12 FMN1 NFIX ATF7IP PHLPP1 PRDM14 ARHGAP21 SOS1	4.38e-03	1434	130	14	EFO_0008354
Disease	schizophrenia, intelligence, self reported educational attainment	ESR2 EPN2 ATF7IP KMT2A DGKI PCNX1	4.40e-03	346	130	6	EFO_0004337, EFO_0004784, MONDO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPRQTPPLQHHGQLA	EP300	726	Q09472
PTGSGPLLHIPHRAI	CCDC112	421	Q8NEF3
ASHFLQPPPHQSIII	BIRC6	1766	Q9NR09
PHIKPLQNLSLHPGS	BCAT1	71	P54687
PHLQRHLPLATVSPG	CAPS	46	Q13938
RSSQALSPHPQPTHL	CD27	131	P26842
GHFTQPILHLPQPEL	BRD4	821	O60885
ELLCRAPSVPGVPHH	ALPK2	1071	Q86TB3
PHTGRLPANHAPDIL	ATP7B	461	P35670
ARVVVPTLKQHSHPP	ARHGEF5	746	Q12774
TLLHHPSVIPQQSPL	ARID2	761	Q68CP9
RPLQSALHHVQPCPA	APCDD1L	241	Q8NCL9
GHCPHPRVLPNLVAV	CMIP	316	Q8IY22
HLHAGPVINTLPPIV	CREBBP	1636	Q92793
PHAPRHRQQSVLLVP	ACAD10	846	Q6JQN1
SVRPGHQEVSVPPHL	ANKRD55	521	Q3KP44
VPPHLRHLHNPSSGQ	ANKRD55	531	Q3KP44
GKPPHISSHPLLQDL	CEP170B	881	Q9Y4F5
HPKDPRGPSVLHNSV	ADAMTS15	811	Q8TE58
RHLPSVSSLPFHPQL	NPIPB3	586	Q92617
LHPALIQRPFGIPAH	RBM24	106	Q9BX46
ALPPRLQHPSGVRQH	OTUD4	376	Q01804
LPPHTQVHGSRLRLP	HSPG2	2091	P98160
RSPHRPLAGLHLSPV	RFT1	456	Q96AA3
LLLLPGRPHPHGQSV	RAB11FIP3	366	O75154
SPHGQTRPPASLKHI	ECT2	716	Q9H8V3
PQQHHRILRLPALPG	FMN1	531	Q68DA7
RHLPSVSSLPFHPQL	NPIPB12	506	F8W0I5
HSAQIAKPIRPGQHP	KIF5B	916	P33176
PVTSPNKHLGLVTPH	CD83	186	Q01151
PVPGSLSSLLHLHNR	CREB5	156	Q02930
HLRPQPPKTQVSSLH	FAM47C	221	Q5HY64
PIARRLGHHPPQSLN	FBXO42	616	Q6P3S6
LGHHPPQSLNVGKPL	FBXO42	621	Q6P3S6
RLHTLPPGLPRNVHV	PODN	441	Q7Z5L7
LAHTGGHQSPLPPLV	KRBA1	951	A5PL33
FTHHPLPVLAGVRPG	NFIX	346	Q14938
SHRQAIPVLHSPTSP	MADCAM1	216	Q13477
HSLPGRIVPPLQHNS	MAJIN	131	Q3KP22
PTPGHLSPLVVHRQL	ESR2	81	Q92731
HSPPLNLPNNSHGIT	MUC15	71	Q8N387
SPVLPSGHHLQIPAH	LRIF1	176	Q5T3J3
GEELLRIAPTPHHTP	ALAS1	566	P13196
RSSLSHLGPQHLPPG	DTX2	281	Q86UW9
QPLSQRHPFLPHLGL	EPN2	221	O95208
VQVPPRIHPTATHHI	HMCN2	971	Q8NDA2
PLPLSQRTLLHGSGH	HMCN2	3361	Q8NDA2
LPHHSSTQPLDLAPG	ATXN1L	211	P0C7T5
LHQVTPVFRHPPCSN	IL12RB2	711	Q99665
PSLQSLHPVSPSHQR	KIAA1614	1046	Q5VZ46
QAPVSRPVLTLHHGP	FCRL6	201	Q6DN72
RPVLTLHHGPADPAV	FCRL6	206	Q6DN72
IHRLLLQPVPHSGSS	PER2	466	O15055
RHNAGSNPTPPTLLI	PCNX1	796	Q96RV3
LQSQPVHPGLLHSSP	KCNN3	91	Q9UGI6
PGQLHPHLTVAKVPH	LENG9	441	Q96B70
FGRHIPPCIHIPLAN	OR52B4	266	Q8NGK2
QLVLVPGHHLQPPAQ	POU2F2	111	P09086
PPGNHSLSLEAPRLH	PDZD3	6	Q86UT5
PPIGHITVHPATLNH	MNT	486	Q99583
RHLPSVSSLPFHPQL	NPIPB5	711	A8MRT5
PLSHHTLPNGQPTVL	FOXP4	271	Q8IVH2
PTTRHSVSHPQLQLP	KIAA1549L	526	Q6ZVL6
FPPGTLLAPRHHVTV	LMNTD2	406	Q8IXW0
HHELPPGSTKRALPN	TP53	296	P04637
VLPSIHQLHPASPRG	HAUS5	476	O94927
RHHLNNPPPSQVGLT	IRS1	286	P35568
RHLPSVSSLPFHPQL	NPIPB4	716	C9JG80
VLVPTRHPHAIPGSI	ODAD1	531	Q96M63
TQPHPHATVIPDRTL	LRRC66	461	Q68CR7
HGTPRALLHPLLQDP	NPHP4	156	O75161
VQLGPQSTHHSPRTP	MED16	851	Q9Y2X0
TQAHPLGPQRAASPL	DCHS2	1106	Q6V1P9
VPTLQHHLAPPAEAR	NR0B1	336	P51843
RHLPSVSSLPFHPQL	NPIPB11	726	E5RHQ5
HRRQLGPQGPPHLVA	GAST	56	P01350
LPPSCPTHRHILQQR	WDPCP	671	O95876
LTLGPTCPHHVPVQV	SLC1A7	521	O00341
HTPGQPLHIKVTPDH	FILIP1L	896	Q4L180
GLQHLAPAHPLSLPV	DGKI	141	O75912
ARAGLPSTHLHVPTP	B3GAT2	131	Q9NPZ5
RLETHVPSPGLTHPA	CRYBG2	356	Q8N1P7
PATPVTLGQHHLPVR	FOXK1	606	P85037
TGPQLTVHHRPPQVH	ATF7IP	1116	Q6VMQ6
HPPPHLKTQLEINGR	MBNL3	71	Q9NUK0
NPSNLHFLSTLPRPH	MAPKBP1	306	O60336
TPVPPSAGHLAHVRE	KANK2	176	Q63ZY3
PPLNPHGSARAEVHL	KMT2A	3756	Q03164
RQPQPVHLLPLHGIQ	LCAT	386	P04180
PALTVHPAHQLGASP	EMX1	126	Q04741
HPGPVNSELFLRHVP	DHRS13	226	Q6UX07
DHIVLHSGQRPPELP	MUCL3	61	Q3MIW9
RHLPSVSSLPFHPQL	NPIPB13	716	A6NJU9
HELHGAQLSLRPAPP	PARP10	71	Q53GL7
LHRIPSAPVIPTHQA	OSBPL7	221	Q9BZF2
TLGPGLQPLPQTSHH	INSL3	86	P51460
NLSLLSPNHSLLPPH	OPRL1	21	P41146
PRPNNLHTLCGAPVH	NRN1L	106	Q496H8
RAPLGAPNPFHLQLH	GRIN3B	136	O60391
TRFPPEPNGILHIGH	QARS1	266	P47897
ELQNPLLPRSPAHLH	SYNDIG1L	6	A6NDD5
HPGLSNLATPHRLAI	SZT2	1676	Q5T011
QASTLLAQGPRPHAP	TMC3	871	Q7Z5M5
PASLHHAISGLLVPP	PRDM14	216	Q9GZV8
VVVIPSIPHPSLNHG	NBEA	1611	Q8NFP9
QSLPTAHVRPSHPLK	NEO1	1346	Q92859
GPRLHQGHATLPTEP	SMIM33	66	A0A1B0GW64
ALLHEGPESPHRPSL	INPP5D	281	Q92835
PHILQGLLSPRHSLT	SIK3	966	Q9Y2K2
LKRHLTPPQGNSPHS	SHROOM3	571	Q8TF72
PASPTHLAHNLLLPV	TEF	111	Q10587
PGLQPHPRIGDHKNI	KIAA0753	196	Q2KHM9
SPPANGLLSPHDVLH	PRR12	176	Q9ULL5
RHLPSPPLTQEVDLH	SOS1	1271	Q07889
GRNHLVLRLHPAPCP	EXTL1	156	Q92935
SRPELHPVQPLALHV	SOX30	121	O94993
HQRLPTLPGISHETP	TET1	1331	Q8NFU7
SPTGPHPLEHLLARL	NDUFV1-DT	16	Q8NBR9
PLSELQPSPHSVHGI	PIK3R4	1231	Q99570
PPHQVLVVPLHSRIS	TSR1	81	Q2NL82
ANLGSTLTPHHPPAL	SPEN	2976	Q96T58
THLASTAAPIPQHLP	RNF111	711	Q6ZNA4
ISHHIPATAPPAQRL	RNF111	731	Q6ZNA4
GPHPPAAHLRSLKSL	TBX2	81	Q13207
RLLPTATTNGHPQLP	PTH1R	521	Q03431
PQSPGLQPLIIHHAQ	TICAM1	671	Q8IUC6
HAVIPTQLPSRPGHR	ZNRF4	26	Q8WWF5
PGLHPQSQLLPSHAS	HIVEP3	136	Q5T1R4
PLHSQHLTRAPCPLI	HIVEP3	2181	Q5T1R4
QASVPPHQLRLGSLH	AXL	286	P30530
HAQLLEQHRGQPLPP	CAD	846	P27708
TPGLLHPQTSPLLHS	CAD	1906	P27708
LTHPSHRLPQQGEKP	ZNF786	281	Q8N393
AHRPLAGAVAHPQPL	TLX1	136	P31314
HQRIHIGESLSPPNP	ZNF570	516	Q96NI8
FLHPSVVPRPHVQSV	PHLPP1	1346	O60346
QHIVRTDLHVQGPPP	TRPC5	386	Q9UL62
LPQRHNSLHRKTPGP	WIPF2	276	Q8TF74
SAASVLHPQQTLHPP	WNK1	2156	Q9H4A3
VLHCHVSTRVGPPNP	TMUB1	166	Q9BVT8
LLHLRASGQPHPTPE	VSIG10L2	21	P0DP72
PLSIPTTHLIHQPAG	ARHGAP21	321	Q5T5U3
LIGQQLQPLSHHAPP	TLE2	121	Q04725
EHNALLHSPGSLTPP	TSHZ1	616	Q6ZSZ6
KLGTQPSLPHVRQPH	USP33	126	Q8TEY7
VHPSPNLILSQKRPH	ZNF81	176	P51508
STLPHRPLLSPSGIH	TRERF1	446	Q96PN7